Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
30
self-reported 11–50 band
Founded
2010
16 years
Legal entities
1
ABR
Office countries
2
2 addresses
Funding rounds
7
Grant · Nov 2024 · US$ 1.6M
Company type
Public Company
self-reported
Legal entity
1 brand → 1 confirmed entity
ATOMO DIAGNOSTICS LIMITED
ABN37142925684
Legal entities
Show as table · Atomo Diagnostics: 1 registry entity
| ATOMO DIAGNOSTICS LIMITED | ABN 37142925684 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Atomo Diagnostics is a medical device manufacturer headquartered in Sydney, Australia with offices in South Africa and the United Kingdom.
Atomo Diagnostics was established to capitalise on a core belief that healthcare products offering significantly improved levels of convenience, simplicity and user experience are disproportionately disruptive and have the potential to be very successful commercial market entrants.
In 2013, Atomo introduced AtomoRapid, a range of safe, simple professional use tests that deliver fast and accurate results in both clinical and community settings. In 2014, AtomoRapid HIV won Best in Show at the Medical Device Excellence Awards (MDEA) and Atomo was named Australian Emerging Company of the Year for 2014 by Johnson & Johnson Innovation.
Atomo is committed to increasing the early detection and ongoing treatment of infectious and chronic diseases by making testing safer, more accurate and more accessible.
Visit our website, www.atomodiagnostics.com, for more information on our company and products.
Locations
2
Countries with an office address2 addresses on record
AustraliaprimarySouth Africa
Country footprint
Show as table · Offices in 2 countries
| Countries | 2 |
|---|---|
| Primary country | AU |
All codes: AU ZA
Addresses
- AULevel 1; 3-5 George Street; Leichhardt, NSW 2040Primary
- ZA4th Floor, West Tower; Nelson Mandela Square; Johannesburg, Gauteng
Grid intelligence Members
Funding
Last round · 22 November 2024US$ 1.6MGrant · investor: Department of Industry, Innovation and Science
Rounds7
Round typeGrant · non-equity funding
Amount (USD)1,600,000
Stage rank1
Investors named1
Since last round1 yr 1 mo
Funding
Show as table · 7 funding rounds
| Rounds | 7 |
|---|---|
| Axis | 2010 to 2026 |
| Grant · 22 Nov 2024 | US$ 1.6M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
FAQ
Which legal entity operates under Atomo Diagnostics?
One New South Wales entity on the ABR: ATOMO DIAGNOSTICS LIMITED (ABN 37 142 925 684), high confidence.
How many people work at Atomo Diagnostics?
30 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Where does Atomo Diagnostics have offices?
Two addresses on record across 2 countries. Primary: Level 1, 3-5 George Street, Leichhardt, NSW 2040.
Has Atomo Diagnostics raised funding?
Seven rounds. Latest 22 November 2024: grant, US$1,600,000, investor Department of Industry, Innovation and Science.
Which companies are listed alongside Atomo Diagnostics?
7 profiles list Atomo Diagnostics as a peer — 80th percentile in Medical Equipment Manufacturing. It lists ten peers of its own.